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Recent studies reporting UV A (ultraviolet A radiation 
320-380 nm) as an integral part of the cumulative sun-
induced damage in human skin have prompted an interest 
in developing effective UV A photoprotective agents. The 
development of such compounds has been impeded by the 
absence of a clinically relevant animal model for evaluating 
their effi cacy. This report describes the development and 
use of such a laboratory animal system. 
Selected concentrations of oxybenzone (2-hydroxy-4-
methoxybenzophenone) in vehicle (0.1 % to 6%) or vehicle 
alone were applied to the depilated dorsal skin of 30 Hartley 
strain female albino guinea pigs. The skin was irradiated 
Although UVA (320- 380 nm) per unit pho ton is ap-proximately one thousandth as erythem ogenic as UVB (290- 320 nm), it is of biologic importance because its concentration iri solar radia tion reaching the ea rth 's surface has been estimated to be 10 to 100 
tim es g reater th an UVB. In addition, its effectiveness in produc-
ing pigmentation is approximately 1/500 that ofUVB per photon, 
making it impo rtant in the solar tanning process [1-5] . Since 
UV A penetrates m ore deeply into the dermis, it plays a m aj or 
role in the sun-induced changes of dermal connective tissue and 
loss o f elas ticity, w hich is evidenced cl inically as aging and w rin-
kling [6]. Recent studies further suggest that UV A radiation acts 
to pro mo te the ca rcinogenic effects o f UVB radiation [7]. 
Radiation in the UV A range has been associated w ith the pro-
du ction o f lesions in a variety of disease states including chemical 
phototoxic and pho toallergic drug reactions, persistent light re-
actions, actinic reticuloid , and solar urticaria [8- 10]. 
Topical sunscreens have been formul ated to protect the skin 
Manuscript received December 22, 1986; accepted for publication March 
10, 1987. 
These studies were supported by a generous gi ft from Westwood Phar-
maceuticals, and NIH grants #1 R23 AM ES 33-663-01 and # 5732 
AM07171. 
Reprint requests to: Stephanie Chew, M.D. , Department of Derm a-
tology, Columbia University, College of Phys icians and Surgeons, 630 
West 168th Street, New York, New York 10032-3784. 
Abbreviations 
BZP: 'oxybenzone 
MED: minimal erythema dose 
8-MO P: 8-methoxypsoralen 
SDS: sodium dodecyl sulfate 
SPF: sun protection fac tor 
TCA: trichloroacetic acid 
UV A: ultrav iolet A (320- 380 nm) 
UVB: ultraviolet B (290- 320 nm) 
with solar simulated UV A from a xenon light source. Acute 
radiation-induced damage w as assayed by erythema grad-
ing and inhibition of[3H]thymidine incorporation into epi-
dermal DNA. D ata from erythema grading studies indi-
cated that a significant degree of photoprotection was 
achieved w ith 6% , 3%, and 1 % solutions ofbenzophenone 
compared with the control vehicle; the 6% solution was 
significantly more photoprotective than the 3% and 1 % 
solutions . A 6% solution afforded significant photopro-
tection when assayed by [3H]thymidine incorporation. ] 
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fro m the dam agin g effects of radiatio n . Until recently, topical 
sunscreening formulatio ns were primaril y developed to protect 
against radiation in the UVB range . Para- aminobenzoic acid 
(PABA) and its es ters have been used m ost extensivel y fo r the 
pas t generation in commercial sunscreens and their absorption in 
the UVB range has been extensively studied [l1-15J . These sub-
stituted benzoic acid nuclei derivatives do not have signifi cant 
absorption potential in the UV A spectrum. Considering the ap-
parent deleterious effect of UV A photons on humans skin , it 
would appear desirable to develop to pical agents that would pro-
tec t against longer wavelengths o f radiatio n . In addition, the use 
of potent UV B sunscreens allows individuals to expose their skin 
to quantities of UV A radiation that would not no rm ally be pos-
sible w ithout UV B pro tection . Such agents would also be usefu l 
in the protection o f selected skin sites in individuals receiving 
phototherapy using long wave ultraviolet, such as PUV A treatment. 
The benzophenones have a broad absorption spectrum in the 
200- 350 nm range, and should theo reticall y protect against both 
UVB and UV A radiation [16]. For this reason , these chemicals 
have been used in recent yea rs in commercial sunscreens, usually 
in co mbination w ith o ther agents [15] . The actual effecti veness 
of benzophenones in photo protection against UV A radiation has 
only been evaluated in m odel system s that utilized exogenous 
photosensitizers [17-21] . B y desigr. , these systems generate data 
concerning pho toprotection th at is limited to the action spectru m 
of the photosensitizer used rather than solar radi ation reaching 
the skin . 
We have selected benzophenones to use in our effo rt to develop 
an ani mal m odel for tes tin g photoprotective agents using full 
range UV A radiation . Recentl y, our group reported a reproduc-
ible m odel for UV A erythem a in guinea pig skin and dem on-
strated a high correlation o f that m odel w ith UV A erythem a in 
human skin [22J. In this report, we extend our o bservations to 
the utilization o f the guinea pig for assess in g UV A sunscreen 
agents. 
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MA TERIALS AND METHODS 
Light Source T est an imals received radiation from the Oriel 
1000 Watt Solar Simulator, which emits a collimated beam with 
an emission spectrum in the UV A range 320-450 nm (Fig 1). A 
?Jter holder on the exit port enables light blocking fi lters to be 
inserted. Any output below 320 nm was blocked w ith UVB and 
UVC fi lters. The lamp was eq uipped w ith an exi t port to ensure 
tha t radiation was delivered to a field size of 15 X 15 cm with 
uniform intensity and minimal peripheral fa ll off. When cali-
brated, a variati on of less th an 10% loss of flu ence is observed 
over the entire fie ld, w ith the main fa ll offnoted near the periphery 
[13]. 
The irradiance in the UV A range was measured with an IL 
700A Radiometer from International Light using a model SEE 
1.15 UVA probe (496 UV A #2028 filter). The distance from the 
light SOurce to the target was 25 cm, delivering an irradiance of 
9.7 m W /cm2• The absence of UVB emission was documented 
by utilizing the same instrumentation with a UVB probe SEE 
12~0. Irradiation time of approximately 40 min was necessary to 
dehver 60 J /cm2 of UVA . . 
Materials Solutions of oxybenzone, USP (2-hydroxy-4-meth-
oxybenzophenone) (BZP) in a vehicle of isopropyl myris tate 30% 
and SO alcohol 40,70% , in concentra tions ranging 0. 1 % to 6%, 
and a vehicle control were obtained fro m Westwood, Inc. (Buf-
falo, New York). 
Animals All studies were performed on Hartley strain albino 
female guinea pigs ranging in weight from 375 to 425 g. The 
arumals had free access to water and standard laboratory food. 
Each animal was used onl y once. ' 
Test Procedures 
E1)'lhema Grading: The dorsal lumbar area of30 guinea pigs was 
clipped and depil ated w ith N air (Carter Products/Division of 
Carter-Wallace, Inc.). Animals manifes ting erythema 20 min later 
were not used in the study. All animals that were irradiated had 
~hite skin that was normal in appearance at the time of irradia-
non. Six areas measurin g 1.5 X 1.5 cm were delineated with light 
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occlusive tape. A volume of approxi mately 0.01 mllcm2 of each 
test material was evenl y applied with a glass rod to each square. 
This quantity of solution is grea ter than th at recommended for 
sun protection fac to r (SPF) testing [23]; it was utilized after pilot 
studies revealed that such a quantity was necessary to cover the 
skin site. T o avoid variability in the erythema response due to 
differences inherent in skin si tes, the solutions were rotated among 
the sites so that each formu lation was used an equal number of 
times in each skin site [24]. The animals were immobilized on a 
metal board and irradiated wi th 60 J /cm2 of UV A. The erythema 
grade was evaluated 6 h after exposure, as outlined in Table I. 
This scale is a modification of that published by Parrish [2]. Our 
previous studies [22] and that of others [15), suggest that the dose 
response curve for UV A erythema is fl atter than that for UVB 
erythema, never exceeding moderate erythema. Therefore, a three 
g rade scale, 0 to 2 +, is more appropriate for evaluatin g the er-
ythema res ponse to UV A. 
[3H]Thyrnidine Incorporation A group of five animals was 
shaved and depilated as outlined above. Three areas (1.5 X 1.5 
cm) of dorsal skin were delineated. One area received an appli-
ca tion of BZP 6%, and vehicle was applied to a second site; the 
third site served as an unirradiated contro l. The two irradiated 
sites received 80 J / cm2 of UV A. The third unirradiated control 
si te was shielded. A dose of80 ]lcm2 was chosen after preliminary 
studies revealed 50% - 60% inhibition of [3H]thymidine incor-
poration at that dose. 
Preliminary studies have documented a UV A-induced inhibi-
tion of DNA synthesis in guinea pig epidermis 3 h after irradiation 
[25] . Epidermal DNA was therefore pulse labeled by an intra-
peritoneal injection of [3H]thymidine (250 /LCi) 2 h after the end 
of the irradiation period. One hour ,after inj ection , the animals 
were sacrificed, and the skin from the dorsal surface was removed 
by derma tone to obtain total epidermis with minimal dermis. A 
pure epidermal sheet was obtained by immersion of the skin in 
trypsin (0.25%) for 14-16 h at 4°C. (This was confirmed in pre-
liminary studies by histologic examination) . The epidermal sheets 
were homogenized in 2% sodium dodecyl sulfate (SDS). DNA 
was precipitated by 10% trichloroacetic acid (TCA) at 4°C and 
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Figure 1. Spectral characteris tics of the Oriel Solar 
Simulator with various fi lters. All studies were per-
formed using UVB and UVC blocking filters. Re-
produced from material supplied by the Oriel 
Corporation. 
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Table I. 
Grade 
0(0) 
1 (+) 
2 (+ +) 
Erythema Grading Scale 
C riteria 
N o erythema 
Minimal but defined erythel'na without 
well-defined border 
Moderate erythema with four sharp borders 
dried w ith eth anol. The precipitated DNA was resolubilized in 
5% T CA at 90°C for 20 min. The [3H]thymidine incorporation 
was determined by scintillation spectroscopy and total DNA con-
tent was determined by spectrophotometry with known stan-
dards [26]. The data were examined in terms of cpm/ l 00 J.Lg DNA 
for each of the three experimental conditions. 
Analysis of Data T he data are presented in terms of mean ± 
standard error of mean (SEM). The data were analyzed using 
Student 's t tes t for paired comparison. 
RESULTS 
The data presented in Fig 2 are the mean erythema grades for the 
six formulations in 30 guinea pigs. It is apparent that the erythema 
grade decreased with increasing concentration of ben-
zophenone; that is, the photoprotection afforded by benzophen-
one was concentration dependent. The erythema grade at 6 h in 
the vehicle control site w as 1.5 ± 0. 11 (mean ± SEM). This 
grade correlated well w ith our previous published report for 6 h 
erythema grading in guinea pig skin [22]. Concentrations of 0.1 % 
and 0.3% benzo phenone produced erythema grades greater than 
1 + and provided very little photoprotection . Significant pho-
to protection was provided by the 1 %, 3%, and 6% solutions 
(p :S 0.01 , O. 001 , O. 001, respectively) w ith erythema grades less 
th an 1 + for the latter two treatments. The 6% solution afforded 
greater protection than the 3%, a difference that was also statis-
tically significant (p :S 0.001). Similarl y, the protection provided 
by the 3% could be differentiated from the protection offered by 
the 1 % solution (p :S 0.01 ). 
The data presented in Fig 3 are the results from the experiment 
in which inhibition of DNA synthesis was used as the endpoint 
to defin e photoprotection . The data are presented in terms of 
percent of control. That is, (cpm/ 100 JLg DNA in irradiated skin 
with vehicle or with BZP -7 cpm/ lOO J.Lg DNA in nonirradiated 
control X 100). 
[3H]Thymidine incorporation into DNA of guinea pig skin w as 
inhibited by UV A irradiation . In this study irradiated control skin 
(vehicle) was found to incorporate only 60% as much [3H]thymidine 
as unirradiated contro l skin . In contras t, pretreatment of irradiated 
skin with BZP 6% resulted in [3H] incorporation of 86% com-
pared with non irradiated control. The BZP, therefore, afforded 
protection against the inhibition of DNA synthesis in epidermis 
irradiated w ith 80 ] / cm2 of UV A. The difference between the 
[3H)thymidine incorporation in vehicle and BZP-treated skin was 
statisti cally significant (p :S 0. 05) . 
DISCUSSION 
UV A radiation, similar to UVB , induces erythema and melan-
ogenesis, but UV A is less effective in producing these effects in 
human skin than UVB [1-5,15]. UV A can also markedly enhance 
the sunburnin g effects of UVB radiation [1 ,7, 10). In addition, 
UVA may enhance the carcinogenic action of UVB [5 ,27 ,28]. 
Discussion of the risks and benefits fo llowing exposure to UVA 
radiation has become considerably important as a consequence of 
proliferation of suntanning salons offering non physiologic amounts 
of UV A irradiation, and w ith increased use of PUV A in the 
treatment of psoriasis and other cutaneous disorders. An ideal 
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sunscreen would thus include protection not only in the UVB 
range but also in the UV A range (320- 400 nm). 
Tes ting of topical agents that offer pro tection against long wave 
ultraviolet radiation is in rudim entary stages. N o one testing sys-
tem is presentl y considered standard by the photobiologic com-
munity. Evaluation of agents affo rdin g pro tection in the UVB 
range, after similar early disco rdance, has been codified in recent 
yea rs by regulato ry agencies (23). This was achieved by general 
acceptance by the scientific community of termin ology such as 
SPF, and testing technology including choice of light sources, 
definition of endpoint, and selection of population. 
The rationale fo r the initial development of sunscreens was to 
produce agents that would protect human skin [rom the acute 
effects of excessive exposure (sunburn) and fro m the long term 
effect of that excess (actinic skin cancer). The action spectrum for 
both of these effects can be assayed by erythema grading, since 
UVB-induced erythema and tumor produ ction have similar ac-
tion spectra [20]. Utilization o f that endpoint w ith the proper 
light source, either natural so lar radiation or artificial sources 
producing solar-simulated radiation has led to clinically relevant 
gradin g of UVB protective agents. 
In 1960, Knox and his colleagues [21] used tumor induction as 
the endpoint fo r evaluating topical protection from Wood's light 
radiation (366 nm) in mice sys temica ll y sensitized to 8-methoxy-
psoralen (8-MOP). Systemically or topically administered 8-MOP 
has also been used to evaluate pro tection aga inst UV A by others 
in mice [1 8, 19] and human volunteers [1 7, 29]. A variety of light 
sources were used in these studies and UV A damage was assayed 
by ear swelling (1 9) an d ornithine decarboxylase activation [18] 
in the mouse models, and erythema gradin g in the human vol-
unteers [1 7, 29]. In addition, other in ves tigato rs have suggested 
using demethylchlo rotetracycline [20] and anthracene as photo-
sensitizing agents in determinin g protecti on in this spectrum [30]. 
Most recently, Kaidbey and Gange have compared photoprotec-
tion against UV A in human volunteers using both normal and 
photosensitized skin (topical 8-M O P and anthracene) assessing 
erythema and pigmentation as endpoints [31] . 
Since our knowledge of the damaging effects of long wave 
radiation is presently undergoing a rapid growth, it is not sur-
prising that so little agreement exists concerning the evaluation 
of products which protect against such ill-defin ed damage. The 
action spectra for most of the deleterious effects ofUV A radiation 
are poorly defined. In the absence of these data, it would not 
appear reasonable to base pro tective fac tor grading against pho-
tons of the UV A range on studies using exogenous pho tosensi-
tizers. Such studies assay protection against radiation onl y in the 
action spectrum of the sensitizer, and more specifically in the 
action spectrum of the photosensitized biologic endpoint chosen 
for assay . Additionally, one must consider the light sources used 
in such studies since the emission spectrum of the source when 
adjusted to the action spectrum of the sensitizer could yield con-
siderable shifting of the "effecti veness spectrum " for the pho-
totoxic endpoint assayed [30]. In their report , Kaidbey and Gange 
concluded that protection fac to rs calculated fro m data obtained 
in artificially sensitized skin "are probably not relevant to normal 
skin ." [31] 
In the absence of more defmiti ve action spectra information 
concernin g damage from long wavelength UV, it is essential to 
mimic natural exposure risks. This necessitates the use of either 
natural solar radiation or artificial solar simulated radiation with 
appropriate filtering. Further, delayed erythema would appear to 
be a physiologicall y relevant endpoint for damage assessment. 
O thers have suggested utilizing pigmentation as an endpoint in 
human skin [31] . This would, of course, be impossible in an albino 
model such as the one described in this communica tion. Our 
previous studies docum ent peak UV A erythema at 6 h in both 
human and guinea pig skin , and therefore, erythema grading in 
our studies was performed at that postirradiation time. 
Recentl y, a number of artificial light sources have been devel-
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Figure 2. The effect of topica l benzophenone (BZP) 
rr~atment on UVA induced erythema in guinea pig 
sk!n. UVA = 60 J/c m2; erythema grade deter-
m ined 6 h pos t irrad iation. Data are presented in 
means ::t SEM for 30 observations. Vehicle control 
va lue is 0 BZP. 
0 .5 
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oped that have irradiance values sufficient to produce UV A er-
ythema with reasonably short radiation time. We have used a 
modification of one of these units (Oriel 1000 Solar Simulator) , 
w hich enables 2 to 3 times minimal erythemogenic doses ofUVA 
to be delivered w ithin two hours. 
The benzophenones exhibit two absorption peaks at 285 nm 
and 330 nm and they should therefore offer protection in both 
the UVB and UVA ranges [1 6]. The data we present documents 
photoprotection of benzophenone solutions against UV A radia-
tion . In fact, the protection afforded by various concentrations 
of BZP in the range studied was dose dependent. Solutions as 
dilute as BZP 1 % were capable of providing statistically signif-
icant protection . The model has also been shown to be capable 
of differentiating the protection offered by 1 % , 3%, and 6% 
solutions. A moderately large number of animals [30] would 
appear necessary to attain significance in such stud ies_ This num-
ber does not appear to be excessive, however, compared with 
o ther studies. Preliminary studies (G. Whitman, V. DeLeo, L. 
Harber, unpublished observations) suggest that such studies could 
also be accomp li shed in human volunteers_ Testing in humans 
w o uld be necessary, of course, for determinin g the level of pro-
Figure 3. The effect of benzophenone (BZP) on 
the UV A-induced inhibition of eH]thymidine in-
co rporation into epidermal DNA. [' HJTh ymidine 
incorporation into epidermal DNA was deter-
mined 3 h after UV A radiation (80 J/cm2) in vehicle 
and BZP 6% trea ted skin and compared with con-
trol (unirrad iated). Data are presented as means ::t 
SEM of observa tions in 5 animals. 
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tection against UV A before agents could be approved for com-
mercial purposes. Such studies reported by Kaidbey and Gange 
[31] revealed that a 3% BZP solution, in a different solvent, 
yielded a protection factor of 1. 5 when measured in human sk in 
as assayed by erythema at 6 h post irradiation. The design of our 
experiment does not allow for generation of a similar protection 
factor, i.e. , we did not expose BZP treated skin to multiples of 
the dose of UV A necessary to induce minimal erythema in guinea 
pig skin. In a previous communication, however, we reported a 
minimal erythema dose (MED) of 45 ]/cm2 in guinea pig skin. 
The erythema grade in our studies in skin treated with 3% BZP 
was less than 1 (less than MED) . Using that figure, the ratio of 
dose for MED in protected/ !Jnprotected skin would be 60/45 or 
at least 1.33. This value appears comparable with the protective 
factor reported by Kaidbey and Gange [31], and suggests that our 
model for assessment of UV A photoprotection correlates well 
with data in human skin. 
In our studies, the quantity ofBZP solutions utilized was g reater 
than that recommended for sun protection factor (SPF) testing in 
humans [23]- Th is quantity was found to be necessa ry to obtain 
coverage of the ex posure sites in guinea pig skin. This difference 
Nonirradiated 
Control 
Irradiated 
with 
BZP- 6% 
Irradiated 
with 
Vehicle 
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in quantity of solution necessary to obtain skin coverage is most 
likely related to differences in vehicles used in our studies and in 
SPF testing as well as differences in the quantity and size of hair 
follicle structures between human and guinea pig skin. It may, 
therefore, be difficult to make direct comparisons · between pro-
tection factors obtained using the model we describe and human 
SPF testing. We feel, however, that this does not lessen the use-
fulness of such a model for preliminary screening of possible 
agents in the early phases of development of new UV A screening 
agents. 
It is apparent that, unlike UVB tes ting, UV A testing will ne-
cessitate development of new terminology for photoprotection. 
Sun protective factor determination would necessitate delivery of 
radiation equal to multiples of the MED in the test subject. Using 
UV A solar simulated light sources now available, radiation of 
only 2-3 MEDs would be possible within a reasonable time. In 
addition to being technically diffIcult, protection from UV A of 
multiples of the MED in human skin would not be necessary in 
the usual clinical set ting , since UV A in natural sun exposure 
would not usually exceed 3 MEDs (-120 Jlcm2) even with con-
tinuous one-day exposure. 
In addition, we have used the UV A-guinea pig model with a 
second, more objective endpoint for damage, UV A-induced in-
hibition of DN A synthesis. A model using the same endpoint in 
hairless mouse skin has been suggested as an excellent screening 
technique for photo protection to UVB radiation (14] . Although 
more labor intensive, it also is relatively simple technologically 
and has the added adval~tage of measuring a defined biochemical 
event-inhibition of DNA synthesis. 
It has been suggested that UVB be extended to include radiation 
in the 320-340mm range, since such radiation may produce effects 
in biologic systems similar to those in the 290-320mm range [32J . 
Our light source has significant radiation in this intermediate 
range. The effect of these wavelengths on erythema and DNA 
synthesis in guinea pig skin requires further study with narrow 
band light sources . 
lt is of great importance that the scientifIC community develop 
a dialogue with regulatory agencies to standardize procedures for 
determining protection factors of topical agents agains t UV A 
radiation damage. The effort will become less difficult as our 
knowledge concerning the mechanisms of damage by this radia-
tion becomes more com plete. 
Finally, the data we present suggest that using the guinea pig 
as a test model for protection against UV A-induced erythema 
with a solar simulated source represents a convenient, relatively 
inexpensive, and accurate model for assessing topical photopro-
tection in the UV A range. 
We are indebted to Debra Hairston for her lillie in the preparatioll of this manuscript. 
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